Connect Biopharma Holdings Ltd ownership disclosure: the filing reports that Biofortune Inc. holds 5,987,431 ordinary shares and that Wubin Pan is the beneficial owner of 6,026,813 ordinary shares of Connect Biopharma (CUSIP 207523101) as reported on 04/14/2026. The filing shows Biofortune Inc. beneficially owns 9.5% of the class while Mr. Pan beneficially owns 9.6%, reflecting shared voting and dispositive power due to Mr. Pan's sole ownership of Biofortune Inc.
Positive
None.
Negative
None.
Insights
Schedule 13G reports a near-10% passive stake held indirectly and directly by the same individual.
The filing shows Biofortune Inc. holds 5,987,431 shares (9.5%) and Wubin Pan beneficially owns 6,026,813 shares (9.6%) as of 04/14/2026. The disclosure attributes shared voting and dispositive power to both the entity and the individual because Mr. Pan is the sole shareholder of Biofortune Inc.
Governance implications hinge on whether these holdings are passive under Schedule 13G conditions; voting alignment is likely given sole ownership. Subsequent filings would show any change in intent or Schedule 13D conversion.
Key Figures
Filing date:04/14/2026Biofortune Inc. shares:5,987,431 sharesWubin Pan beneficial ownership:6,026,813 shares+3 more
6 metrics
Filing date04/14/2026Schedule 13G signature date
Biofortune Inc. shares5,987,431 sharesheld of record by Biofortune Inc.
Wubin Pan beneficial ownership6,026,813 sharestotal beneficial ownership including spouse-held shares
Biofortune Inc. percent of class9.5%percentage of ordinary shares
Wubin Pan percent of class9.6%percentage of ordinary shares
"Item 1. Name of issuer: Connect Biopharma Holdings Ltd"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Beneficial ownershipfinancial
"Mr. Pan is the beneficial owner of 6,026,813 Ordinary Shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Shared dispositive powerregulatory
"Shared Dispositive Power 5,987,431.00"
CUSIPregulatory
"CUSIP Number(s): 207523101"
A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.
What stake does CNTB Schedule 13G show for Biofortune Inc?
Biofortune Inc. beneficially owns 5,987,431 shares (9.5%). The filing lists shared voting and dispositive power over those shares and identifies Biofortune Inc. as organized in the British Virgin Islands.
How many Connect Biopharma (CNTB) shares does Wubin Pan beneficially own?
Wubin Pan beneficially owns 6,026,813 shares (9.6%). That total includes 5,987,431 shares held by Biofortune Inc. and 39,382 shares held of record by Mr. Pan's spouse.
Does the filing indicate who controls the Biofortune Inc. stake in CNTB?
Yes — Mr. Pan is the sole shareholder of Biofortune Inc. The filing states Mr. Pan may be deemed to share beneficial ownership over the securities held of record by Biofortune Inc.
What voting and disposition powers are reported for these CNTB holdings?
Both Biofortune Inc. and Mr. Pan report zero sole voting or dispositive power. The filing shows shared voting power of 5,987,431 for Biofortune Inc. and shared voting/dispositive power of 6,026,813 for Mr. Pan.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Connect Biopharma Holdings Ltd
(Name of Issuer)
Ordinary Shares, par value $0.000174 per share
(Title of Class of Securities)
207523101
(CUSIP Number)
04/14/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
207523101
1
Names of Reporting Persons
BioFortune Inc
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
VIRGIN ISLANDS, BRITISH
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
5,987,431.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
5,987,431.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
5,987,431.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.5 %
12
Type of Reporting Person (See Instructions)
CO
SCHEDULE 13G
CUSIP Number(s):
207523101
1
Names of Reporting Persons
Wubin Pan
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CANADA (FEDERAL LEVEL)
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
6,026,813.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
6,026,813.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,026,813.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.6 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Connect Biopharma Holdings Ltd
(b)
Address of issuer's principal executive offices:
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO, CALIFORNIA, 92130.
Item 2.
(a)
Name of person filing:
Each of the following is hereinafter individually referred to as a "Reporting Person" and collectively as the "Reporting Persons." This statement is filed on behalf of:
Biofortune Inc.
Wubin Pan
(b)
Address or principal business office or, if none, residence:
The registered address of Biofortune Inc. is c/o Biofortune Inc., Coastal Building, Wickham's Cay II, P.O. Box 2221, Road Town, Tortola, British Virgin Islands. The business address of the reporting person is: Suite 103, Building #3, Shu-Yuan Road No. 99, Taicang, JiangSu Province, China
(c)
Citizenship:
Biofortune Inc. is organized under the laws of the British Virgin Islands, Wubin Pan is a citizen of Canada.
(d)
Title of class of securities:
Ordinary Shares, par value $0.000174 per share
(e)
CUSIP Number(s):
207523101
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Mr. Pan is the beneficial owner of 6,026,813 Ordinary Shares, which consist of (i) 5,987,431 Ordinary Shares held of record by Biofortune Inc. and (ii) 39,382 Ordinary Shares held of record by Mr. Pan?s spouse. Mr. Pan is the sole shareholder of Biofortune Inc. As a result, Mr. Pan may be deemed to share beneficial ownership over the securities held of record by Biofortune Inc.
(b)
Percent of class:
Biofortune Inc.:9.5%
Wubin Pan: 9.6%
Note: The ownership information presented herein represents beneficial ownership of Ordinary Shares as of March 31, 2026, based upon 62,651,282 Ordinary Shares outstanding as disclosed in the Issuer?s Form 10-K and Form 8-K filed with SEC on March 31, 2026.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Biofortune Inc.:0
Wubin Pan: 0
(ii) Shared power to vote or to direct the vote:
Biofortune Inc.: 5,987,431
Wubin Pan: 6,026,813
(iii) Sole power to dispose or to direct the disposition of:
Biofortune Inc.:0
Wubin Pan: 0
(iv) Shared power to dispose or to direct the disposition of:
Biofortune Inc.: 5,987,431
Wubin Pan: 6,026,813
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
Not Applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
